These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3369126)

  • 1. [Excretion of monoamines, their precursors and metabolites in the hyperactivity syndrome in mentally defective children].
    Turova NF; Misionzhnik EIu; Ermolina LA; Aziavchik AV; Krasov VA
    Vopr Med Khim; 1988; 34(1):47-50. PubMed ID: 3369126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sidnocarb treatment of young schoolchildren with the hyperdynamic syndrome].
    Krasov VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(8):97-101. PubMed ID: 3195293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EEG changes after mesocarb in respondent and nonrespondent hyperkinetic children.
    Drtílková I; Misurec J; Balastíková B; Náhunek K; Výborová L; Sindelárová M
    Act Nerv Super (Praha); 1989 Apr; 31(1):50. PubMed ID: 2782000
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of biogenic amines in the pathogenesis of intellectual disorders in children with minimal psychoorganic syndromes].
    Lupandin VM; Lando LI; Gromova EA; Kamenskaia VM; Zykov MB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(10):1538-44. PubMed ID: 716733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
    Marcus SC; Wan GJ; Kemner JE; Olfson M
    Arch Pediatr Adolesc Med; 2005 Jun; 159(6):572-8. PubMed ID: 15939858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of psychotropic drug use in children and adolescents.
    Bonati M; Clavenna A
    Int Rev Psychiatry; 2005 Jun; 17(3):181-8. PubMed ID: 16194789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Attention deficit hyperactivity syndrome].
    Sell-Salazar F
    Rev Neurol; 2003 Aug 16-31; 37(4):353-8. PubMed ID: 14533112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate HCl: therapy for attention deficit hyperactivity disorder.
    Capp PK; Pearl PL; Conlon C
    Expert Rev Neurother; 2005 May; 5(3):325-31. PubMed ID: 15938665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discussion on integrated pharmacologic treatment of attention-deficit hyperactivity disorder (ADHD).
    Hendren RL
    Essent Psychopharmacol; 2005; 6(5):291-300. PubMed ID: 16222913
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperkinetic syndrome in childhood. Diagnostic and psychopharmaceutical treatment].
    Hundevadt L
    Tidsskr Nor Laegeforen; 1986 Sep; 106(25):2023-6. PubMed ID: 3775723
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy with convulex in patients with disorders of concentration and of the visual motor system].
    Spiel W; Schuch B; Widmer U
    Wien Med Wochenschr Suppl; 1979; 57():1-7. PubMed ID: 382644
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
    Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T
    Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine.
    Shekim WO; Javaid J; Davis JM; Bylund DB
    Biol Psychiatry; 1983 Jun; 18(6):707-14. PubMed ID: 6871304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children.
    Mosholder AD; Gelperin K; Hammad TA; Phelan K; Johann-Liang R
    Pediatrics; 2009 Feb; 123(2):611-6. PubMed ID: 19171629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavior-disordered and aggressive children: new advances in pharmacotherapy.
    Campbell M; Anderson LT; Green WH
    J Dev Behav Pediatr; 1983 Dec; 4(4):265-71. PubMed ID: 6582068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Old drugs learn new tricks: insights from mammalian trace amine receptors.
    Kim KA; von Zastrow M
    Mol Pharmacol; 2001 Dec; 60(6):1165-7. PubMed ID: 11723221
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder.
    Kariyawasam SH; Zaw F; Handley SL
    Neuro Endocrinol Lett; 2002 Feb; 23(1):45-8. PubMed ID: 11880861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal brain dysfunction (neurological impairment) in children.
    Werry JS
    N Z Med J; 1974 Aug; 80(521):94-100. PubMed ID: 4608527
    [No Abstract]   [Full Text] [Related]  

  • 20. [Psychiatry--chemistry of the mind].
    Larsen L
    Sygeplejersken; 1997 Nov; 97(46):18-20. PubMed ID: 9431124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.